Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Evolution of TP53 abnormalities during CLL disease course is associated with telomere length changes

Fig. 3

Relative telomere length dynamics and BCR signaling activity. Prior clonal evolution, RTL was A) lower in CLL samples with less phosphorylated ERK1/2 (Pearson r = 0.63; P = 0.04) and B) less phosphorylated ZAP-70/SYK (Pearson r = 0.60; P = 0.05). In later stages, RTL was C) lower in CLL cases with less phosphorylated ERK1/2 (Pearson r = 0.66; P = 0.04), D) less phosphorylated ZAP-70/SYK (Pearson r = 0.79; P = 0.01), and E) less phosphorylated NFkB (Pearson r = 0.70; P = 0.02)

Back to article page